(Q35848823)

10 August 2017

1 reference

title

Adrenoleukodystrophy: phenotypic variability and implications for therapy (English)

1 reference

10 August 2017

H. W. Moser

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1528023

5 October 2022

A. B. Moser

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1528023

5 October 2022

K. D. Smith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1528023

5 October 2022

A. Bergin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1528023

5 October 2022

J. Borel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1528023

5 October 2022

J. Shankroff

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1528023

5 October 2022

O. C. Stine

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1528023

5 October 2022

C. Merette

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1528023

5 October 2022

J. Ott

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1528023

5 October 2022

W. Krivit

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1528023

5 October 2022

language of work or name

1 reference

1 January 1992

1 reference

Journal of Inherited Metabolic Disease

10 August 2017

published in

1 reference

10 August 2017

volume

15

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

645-664

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01799621

10 August 2017

exact match

0 references

cites work

The use of immunosuppressive agents in the treatment of multiple sclerosis: a critical review

1 reference

https://api.crossref.org/works/10.1007%2FBF01799621

Adrenomyeloneuropathy: A probable variant of adrenoleukodystrophy I. Clinical and endocrinologic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01799621

The trials of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01799621

Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01799621

Childhood adrenoleukodystrophy. Failure of intensive immunosuppression to arrest neurologic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01799621

Dietary erucic acid therapy for X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01799621

Adrenoleukodystrophy. A clinical and pathological study of 17 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01799621

Arachidonic acid metabolism in fibroblasts from patients with peroxisomal diseases: response to interleukin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01799621

Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro

21 January 2018

1 reference

12 December 2020

Adrenomyeloneuropathy presenting as Addison's disease in childhood

1 reference

12 December 2020

Clinical improvement of adrenoleukodystrophy following intravenous gammaglobulin therapy

1 reference

12 December 2020

Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy

1 reference

12 December 2020

Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels

1 reference

12 December 2020

Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy.

1 reference

12 December 2020

Adreno-leukodystrophy (adreno-testiculo-leukomyelo-neuropathic-complex).

1 reference

12 December 2020

Cognitive impairment in adult-onset adrenoleukodystrophy

1 reference

12 December 2020

Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids

1 reference

12 December 2020

Adrenoleukodystrophy: a correlation between saturated very long-chain fatty acids in mononuclear cells and phenotype

1 reference

12 December 2020

The design of a diet restricted in saturated very long-chain fatty acids: therapeutic application in adrenoleukodystrophy

1 reference

12 December 2020

Linkage of adrenoleukodystrophy to a polymorphic DNA probe

1 reference

12 December 2020

The Ratio of Trienoic: Tetraenoic Acids in Tissue Lipids as a Measure of Essential Fatty Acid Requirement

1 reference

12 December 2020

The red-green visual pigment gene region in adrenoleukodystrophy

1 reference

12 December 2020

A correlative study of the adrenal cortex in adreno-leukodystrophy--evidence for a fatal intoxication with very long chain saturated fatty acids

1 reference

12 December 2020

Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells

1 reference

12 December 2020

Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes

1 reference

12 December 2020

Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin

1 reference

12 December 2020

Adrenoleukodystrophy. Failure of immunosuppression to prevent neurological progression

1 reference

12 December 2020

Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation

1 reference

12 December 2020

A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.

1 reference

12 December 2020

Platelet dysfunction in the neonate with essential fatty acid deficiency

1 reference

12 December 2020

Bone marrow transplant in adrenoleukodystrophy

1 reference

12 December 2020

Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids

1 reference

12 December 2020

Clinical variation in X-linked adrenoleukodystrophy: fatty acid and lipid metabolism in cultured fibroblasts

1 reference

12 December 2020

MRI detects cerebral involvement in neurologically asymptomatic patients with adrenoleukodystrophy

1 reference

12 December 2020

Clinical Aspects of Adrenoleukodystrophy and Adrenomyeloneuropathy

1 reference

12 December 2020

Frequent alterations of visual pigment genes in adrenoleukodystrophy

1 reference

12 December 2020

Color vision defects in adrenomyeloneuropathy

1 reference

12 December 2020

Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids.

1 reference

12 December 2020

Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy

1 reference

12 December 2020

The significance of the "dying back" process in experimental and human neurological disease

1 reference

12 December 2020

Brain tissue immunoglobulins in adrenoleukodystrophy: A comparison with multiple sclerosis and systemic lupus erythematosus

1 reference

12 December 2020

Neuroepidemiology. Part II: Assessment of therapeutic trials

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01799621

1 reference

10 August 2017

1 reference